期刊文献+

WTp53基因联合TK/GCV、CD/5-FC系统抑制结肠癌肝转移的实验研究 被引量:1

Inhibitory effects of WTp53 gene in combination with TK/GCV and CD/5-FC systems on liver metastasis of colon carcinoma in nude mice
原文传递
导出
摘要 目的研究WTp53基因联合TK/GCV、CD/5-FC系统对结肠癌肝转移的抑制作用。方法32只裸鼠随机分为4组,每组8只。脾内注射法建立结肠癌肝转移动物模型。第1组:脾内注射SW480细胞(对照组);第2组:脾内注射SW480/p53细胞;第3组:脾内注射SW480/TK-CD细胞,腹腔注射GCV、5-FC;第4组:脾内注射SW480/p53与SW480/TK-CD等比例混合细胞,腹腔注射GCV、5-FC。观察各组裸小鼠的肝转移率、肝转移瘤数目、肿瘤细胞凋亡指数(AI)、生存期等指标。结果各治疗组裸鼠肝转移的发生率下降,平均肝转移瘤数减少,其动物的生存期延长,肝转移瘤内的癌细胞凋亡率增高。联合基因治疗组效果最好,且WTp53与TK/GCV、CD/5-FC有交互协同作用。结论WTp53基因与TK/GCV、CD/5-FC系统联合应用具有协同效应,可有效地抑制结肠癌肝转移的形成。 Objective To investigate the inhibitory effects of WTp53 gene in combination with TK/GCV and CD/5-FC systems on liver metastasis of colon carcinoma. Methods Thirty-two nude mice were randomized into 4 groups with 8 in each. The model of liver metastasis of colon carcinoma was established by spleen injection. In group A, the mice were injected with SW480 alone into the spleen. The animals in group B were injected with SW480/p53 cells into the spleen. In group C, the mice were injected with SW480/TK-CD cells into the spleen and intraperitoneal injection of GCV and 5-FC. The mice in group D were injected with SW480/p53 and SW480/TK CD into the spleen. Liver metastatic rate, number of liver metastasis, tumor cell apoptotic index and life span and other indexes of nude mice in the 4 groups were determined and compared. Results The metastatic rate of colon carcinoma was lower in groups B, C and D than in group A. The average number of liver metastasis decreased, life span of nude mice prolonged and the apoptotic index of cancer cells in the liver metastasis increased in groups B, C and D than in group A. The combined genes in group D worked the best and there was mutual effect between WTp53 and the combination of TK/GCV and CD/5-FC. Conclusions Synergistic effect is acquired by combining WTp53 gene with TK/GCV and CD-5-FC systems. This combination can efficiently inhibit the formation of liver metastasis of colon carcinoma.
出处 《中华肝胆外科杂志》 CAS CSCD 2007年第10期690-693,共4页 Chinese Journal of Hepatobiliary Surgery
基金 山东省自然科学基金资助项目(Y2003C11)
关键词 结肠肿瘤 肝转移 裸鼠 p53 TK GCV CD 5-FC 基因治疗 Colonic neoplasms Liver metastasis Nude mouse p53 Thymidine kinase Gancicloyir Cytosine deminase 5-fluorocytosine Gene therapy
  • 相关文献

参考文献9

  • 1Otchy D, Hyman NH, Simmang C, et al. Practice parameters for colon cancer. Dis Colon Rectum, 2004,47 : 1269-1284.
  • 2ZhaoY, Zhu WG. Acetylation of 2006 at lysine 373/382 by the histone deacetylase inhibitor depsipeptide induces expression of p21 Wafl/Cipl. Mol Cell Biol,2006,26:2782-2790.
  • 3Vikhanskaya F, D'Incalci M,Broggini M. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line. Nucleic Acids Res, 2000, 28: 513-519.
  • 4Cascinu S, Aschele C, Barni S, et al. Thymidylate synthase protein expression in advanced colon cancer: correlation with the site of metastasis and the clinical response to leucovorin modulated bolus 5-fluorouracil. Clin Cancer Res, 1999,5 : 1996- 1999.
  • 5董泾青,马道新,刘茂玲,邹声泉.双自杀基因系统对体内外胆管癌抑制作用的实验研究[J].中国普通外科杂志,2005,14(11):842-846. 被引量:2
  • 6Hairi A, Wack S, Lehn P, et al. Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes. Cancer Gene Ther, 2004,11:16-17.
  • 7龚丽明,林世杰,王忠明.肿瘤的自杀基因治疗研究进展[J].肿瘤防治杂志,2004,11(5):539-542. 被引量:6
  • 8魏冬,何庆泗,吴雪,谭伟,牛洪欣.WTp53基因联合TK/GCV、CD/5-Fc系统治疗人结肠癌的实验研究[J].中国现代普通外科进展,2005,8(6):342-345. 被引量:3
  • 9Goncalves MA, Van der Velde I, Knaan-Shanzer S, et al. Stable transduction of large DNA by high-capacity adenoasso- ciated Virus/adenovirus hybrid vectors. Virology, 2004, 321:287-296.

二级参考文献26

  • 1常新忠,王占民,马道新,孙建芝,李志伟.联合应用双自杀基因对SW1990细胞的杀伤作用[J].中国现代普通外科进展,2004,7(4):223-225. 被引量:3
  • 2邹声泉 见:邹声泉 龚建平.胆道外科[A].见:邹声泉,龚建平.外科学-前沿与争论[M].北京:人民卫生出版社,2003.602.
  • 3Yazawa K, Fisher WE, Brunicardi FC. Current progress in suicide gene therapy for cancer [ J ]. World J Surg, 2002, 26(7): 783 -789.
  • 4Brade AM, Szmitko P, Ngo D, et al. Heat-directed suicide gene therapy for breast cancer [ J ] . Cancer Gene Ther, 2003 ,10(4): 294 -301.
  • 5Misumi M, Suzuki T, Moriuchi S, et al. In vitro thymidine kinase/ganciclovir-based suicide gene therapy using replication defective herpes simplex virus- 1 against leukemic B- cell malignancies (MCL, HCL, B-CLL) [J]. Leuk Res, 2003, 27(8): 695 -699.
  • 6Ueda K, Iwahashi M, Nakamori M, et al. Carcinoembryonic antigen-specific suicide gene therapy of cytosine deaminase/5-fluorocytosine enhanced by the cre/loxP system in the orthotopic gastric carcinoma mode [J]. Cancer Res, 2001, 61 (16):6158 -6162.
  • 7Park HS, Cheon J, Cho HY, et al. In vivo characterization of a prostate-specific antigen promoter-based suicide gene therapy for the treatment of benign prostatic hyperplasia [ J ]. Gene Ther, 2003, 10(13): 1129 -1134.
  • 8Hoganson DK, Batra RK, Olsen JC , et al. Comparison of the effects of three different toxin genes and their levels of expression on cell growth and bystander effect in lung adenocarcinoma [ J ] .Cancer Res, 1996, 56(6): 1315- 1323.
  • 9Hajri A, Wack S, Lehn P, et al. Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes [ J]. Cancer Gene Ther, 2004, 11(1): 16 -27.
  • 10Black ME,Kokoris MS,Sabo P,et al.Herpes simplex virus-1thymidine kinase mutants created by semi-radom sequence mutagenesis improve prodrug-mediate tumor cell killing[J].Cancer Res,2001,61(7):3022-3027.

共引文献8

同被引文献6

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部